Home › J&J's Quarterly Results Not Reflective Of Underlying Strength
 

Keywords :   


J&J's Quarterly Results Not Reflective Of Underlying Strength

2015-08-13 15:34:52| Biotech - Topix.net

But from our perspective, underlying growth remains prevalent throughout Johnson & Johnson's portfolio, and we think its pharmaceutical portfolio remains a bright spot. Johnson & Johnson reported 2015 second-quarter results July 14. Though the healthcare and consumer goods giant experienced quarterly revenue and adjusted earnings-per-share declines of 8.8% and 3.9% during the period, respectively, both numbers beat consensus estimates.

Tags: results strength underlying quarterly

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Graphics
More »